Alphatec Holdings, Inc. reported $815M of revenue over the trailing twelve months, +19% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $815M (to Q2 2026). Net income: −$110M, trailing twelve months to Q2 2026. Free cash flow: $2.3M, trailing twelve months to Q2 2026. Operating margin: −6.2%, trailing twelve months to Q2 2026.

ATECAlphatec Holdings, Inc.

Healthcare

$10.67-31% 1Y

$10.67

$6.9952 weeks$22.68

ATEC as reported

Alphatec Holdings, Inc. reported $815M of revenue over the trailing twelve months, +19% on the year before. 10 reported series are charted on this page, each one as filed.

$815M

Revenue, trailing twelve months · to Q2 2026 · +19% against the twelve months before

Net income: −$110M
Net income · −34% year on year · trailing twelve months to Q2 2026
Free cash flow: $2.3M
Free cash flow · −110% year on year · trailing twelve months to Q2 2026
Operating margin: −6.2%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for ATEC, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$815M	+19%	Q2 2026
Net income	−$110M	−34%	Q2 2026
EPS	−$0.72	−36%	Q2 2026
Gross margin	71%	n/a	Q2 2026
Operating margin	−6.2%	n/a	Q2 2026
Net margin	−14%	n/a	Q2 2026
ROE	189%	n/a	Q2 2026
ROA	−17%	n/a	Q2 2026
ROIC	−12%	n/a	Q2 2026
Free cash flow	$2.3M	−110%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.